Rather than tumor size alone, the American Thyroid Association’s risk stratification system should be used when assessing papillary thyroid microcarcinomas, according to data published in The Journal ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

Professor Park Jung-je of the Department of Otolaryngology and Otolaryngology at Gyeongsang National University Hospital ...

Paul Cauthen hit a life milestone by celebrating a birthday over the weekend, and that is big for anyone in the fight against ...

A new research has concluded that consumers currently taking a GLP-1RA consume significantly fewer calories than the other ...

Paul Cauthen announced he has cancer just weeks ago, but he apparently is not slowing down much. He already announced shows for May, and he shared video of him playing and singing in a small venue — ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

An Okanagan man is suing Interior Health and several doctors for malpractice after a cancer misdiagnosis delayed care and ...

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Following a five-month cancer battle, Dave Coulier reflected on his experience going through multiple rounds of chemotherapy before learning he was finally cancer-free.

Teddi Mellencamp, who is battling stage four melanoma, revealed that her doctors have given her 50/50 odds of beating her cancer as she undergoes immunotherapy.

Fatigue is a common symptom of thyroid disease. If you’ve ever experienced thyroid fatigue, you’re aware that it isn’t simply like having a night of poor sleep or feeling overly stressed. For many ...